In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
As of close of business last night, Vera Therapeutics Inc’s stock clocked out at $22.79, down -1.13% from its previous closing price of $23.05. In other words, the price has decreased by -$1.13 from its previous closing price. On the day, 0.78 million shares were traded. VERA stock price reached its highest trading level at $23.8 during the session, while it also had its lowest trading level at $22.69.
Ratios:
To gain a deeper understanding of VERA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 27.30 and its Current Ratio is at 27.30. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.10.
On February 04, 2025, Wolfe Research started tracking the stock assigning a Outperform rating and target price of $49.
On January 28, 2025, Goldman started tracking the stock assigning a Buy rating and target price of $58.Goldman initiated its Buy rating on January 28, 2025, with a $58 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jun 23 ’25 when ENRIGHT PATRICK G bought 209,393 shares for $20.87 per share. The transaction valued at 4,369,676 led to the insider holds 3,569,522 shares of the business.
ENRIGHT PATRICK G bought 40,607 shares of VERA for $907,635 on Jun 24 ’25. The Director now owns 3,596,593 shares after completing the transaction at $22.35 per share. On Feb 21 ’25, another insider, Fordyce Marshall, who serves as the PRESIDENT AND CEO of the company, sold 10,613 shares for $27.89 each. As a result, the insider received 296,032 and left with 213,740 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VERA now has a Market Capitalization of 1453414016 and an Enterprise Value of 967150144.
Stock Price History:
The Beta on a monthly basis for VERA is 1.18, which has changed by -0.32384866 over the last 52 weeks, in comparison to a change of 0.13161862 over the same period for the S&P500. Over the past 52 weeks, VERA has reached a high of $51.61, while it has fallen to a 52-week low of $18.53. The 50-Day Moving Average of the stock is -0.17%, while the 200-Day Moving Average is calculated to be -29.71%.
Shares Statistics:
It appears that VERA traded 1.76M shares on average per day over the past three months and 864620 shares per day over the past ten days. A total of 63.77M shares are outstanding, with a floating share count of 45.50M. Insiders hold about 28.65% of the company’s shares, while institutions hold 90.14% stake in the company. Shares short for VERA as of 1749772800 were 9560166 with a Short Ratio of 5.00, compared to 1747267200 on 7069204. Therefore, it implies a Short% of Shares Outstanding of 9560166 and a Short% of Float of 17.28.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
